FGF12 and opioid use disorder: By identifying Fgf12 as a novel candidate gene and highlighting its epistatic interaction with Oprm1, this study sets the stage for a paradigm shift in our approach to opioid use disorder, from focusing solely on receptor-level pharmacology to embracing complex genetic and signaling networks.